Grail surges 55% after FDA panel backs Galleri test
Grail shares climbed 55 percent through Friday morning after a Food and Drug Administration advisory panel voted to recommend the company's Galleri mu
Grail
Every Fin-node story mentioning Grail — 2 stories, newest first.
Grail · 2 stories
Grail shares climb on FDA meeting date for Galleri test
Grail stock gained 15.8 percent in August, according to S&P Global Market Intelligence, but the advance was split cleanly in two. The first half of th